JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

Verastem Inc

Closed

8 2.56

Overview

Share price change

24h

Current

Min

8

Max

8.16

Key metrics

By Trading Economics

Income

26M

-26M

Sales

2.1M

2.1M

Profit margin

-1,213.57

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+90.82% upside

Dividends

By Dow Jones

Next Earnings

4 lis 2025

Market Stats

By TradingEconomics

Market Cap

377M

Previous open

5.44

Previous close

8

Verastem Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 maj 2025, 19:14 UTC

Major Market Movers

Verastem Ovarian-Cancer Drug Combination Gets FDA Approval -- Update

31 gru 2024, 19:15 UTC

Major Market Movers

Verastem Shares Soar on FDA Priority Review of Cancer Treatment

Peer Comparison

Price change

Verastem Inc Forecast

Price Target

By TipRanks

90.82% upside

12 Months Forecast

Average 15.17 USD  90.82%

High 20 USD

Low 13 USD

Based on 7 Wall Street analysts offering 12 month price targets forVerastem Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

7 ratings

7

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Verastem Inc

There is no Profile data available for 2VS.SG.
help-icon Live chat